Document Type
News Article
Publication Date
6-24-2015
Category
News
Creative Commons License
In Copyright
Supplemental Associated Link
http://www.healio.com/rheumatology/rheumatoid-arthritis/news-archive/online/%7Bd32520eb-77aa-4583-b138-41753d2e0396%7D/risk-characterization-approach-enables-safety-comparisons-between-xeljanz-tnf-inhibitors?sc_trk=internalsearch
Recommended Citation
Staff, "Risk characterization approach enables safety comparisons between Xeljanz, TNF inhibitors" (2015). Browse All News. 598.
https://digitalcommons.library.uab.edu/all-news2/598
